SCHEMBL2506549

SCHEMBL2506549

C(=C(c1ccccc1)c1cccc2ccccc12)c1ccc(-c2ccc(C=C(c3ccccc3)c3cccc4ccccc34)c3ccccc23)c2ccccc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR4A1 P22736 1/20 0.43
NR4A2 P43354 1/20 0.43
NR4A3 Q92570 1/20 0.43
CDC25B P30305 1/20 0.39
TBXAS1 P24557 1/20 0.38
CYP1A2 P05177 2/20 0.38
CYP3A4 P08684 2/20 0.38
CYP2D6 P10635 2/20 0.38
CYP2C9 P11712 2/20 0.38
CYP2C19 P33261 2/20 0.38
MMP3 P08254 1/20 0.37
HDAC8 Q9BY41 1/20 0.37
EGFR P00533 1/20 0.36
MAPK10 P53779 1/20 0.36
DDR1 Q08345 1/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
MEN1 O00255 2/20 0.36
MAPT P10636 2/20 0.36
HTT P42858 2/20 0.36
KMT2A Q03164 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2506548 1.00 NR4A1 (0.43) NR4A1NR4A2NR4A3CDC25BTBXAS1
SCHEMBL2510220 0.83 CYP19A1 (0.42) CYP1A2CYP2D6CYP2C9CYP2C19L3MBTL1
SCHEMBL5877773 0.80 NR4A1 (0.48) NR4A1NR4A2NR4A3CDC25BTBXAS1
SCHEMBL4243280 0.78 KMT2A (0.39) NR4A1NR4A2NR4A3TBXAS1EGFR
SCHEMBL7695549 0.78 KDM4E (0.47) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL2508288 0.77 CES2 (0.40) TBXAS1CYP3A4EGFRMEN1MAPT
SCHEMBL2508290 0.77 CES2 (0.40) TBXAS1CYP3A4EGFRMEN1MAPT
SCHEMBL9806354 0.76 NR4A1 (0.52) NR4A1NR4A2NR4A3CDC25BTBXAS1
SCHEMBL9806349 0.76 NR4A1 (0.52) NR4A1NR4A2NR4A3CDC25BTBXAS1
SCHEMBL13508420 0.76 CYP1A2 (0.42) NR4A1NR4A2NR4A3CDC25BTBXAS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110241558-A1 Light-Emitting Device and Driving Method Thereof SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2011-10-06 US disclosed
US-20100156957-A1 ORGANIC COMPOUND, ANTHRACENE DERIVATIVE, AND LIGHT-EMITTING ELEMENTS, LIGHT-EMITTING DEVICES, ELECTRONIC DEVICES, AND LIGHTING DEVICES USING THE ANTHRACENE DERIVATIVE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2010-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100156957-A1 ORGANIC COMPOUND, ANTHRACENE DERIVATIVE, AND LIGHT-EMITTING ELEMENTS, LIGHT-EMITTING DEVICES, ELECTRONIC DEVICES, AND LIGHTING DEVICES USING THE ANTHRACENE DERIVATIVE GLB1, CYP1A1, CRY1 NR4A1 953/4885NR4A2 1063/4885NR4A3 2210/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.